We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Half of Heart Attack Patients Are Unnecessarily Treated With Beta Blockers, Study Finds

Someone pouring white pills out of an orange pill bottle into their hand.
Credit: Towfiqu barbhuiya / Unsplash.
Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 2 minutes

Half of all patients discharged from hospital after a heart attack are treated with beta-blockers unnecessarily. This is according to a new study published in the New England Journal of Medicine.

"I am convinced that this will influence future practice," says Tomas Jernberg, Professor at Karolinska Institutet and lead researcher of the study.

Today, when patients are discharged from hospitals after an acute heart attack, they are regularly treated with beta-blocker drugs such as metoprolol and bisoprolol.

Want more breaking news?

Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.

Subscribe for FREE

Now new research shows that about half of them do not benefit from the treatment and should not receive it at all. These are the patients who have suffered a small heart attack and have retained heart function afterwards.

The study will change the way patients are treated in the future, says the lead researcher and last author of the study, Professor Tomas Jernberg from the Department of Clinical Sciences at Karolinska Institutet.

"I am convinced that this will influence future practice. This study has already been mentioned in the European guidelines for cardiac care, so the results are in demand," he says.

The project was led by researchers at Karolinska Institutet, Lund University and Uppsala University.

More than 5,000 patients at 45 hospitals in Sweden, Estonia and New Zealand who suffered a small heart attack were randomized to either receive or not receive beta-blockers at discharge.

The study began in September 2017 and patients were followed up until November 2023, by which time 7.9 percent of those receiving beta-blockers had the primary outcome of death or a new heart attack, compared to 8.3 percent of those not receiving beta-blockers.

This difference is not statistically significant. Nor was there any difference between the groups in the secondary outcomes.

Drug treatment becomes simpler

The result means that, unusually, the drug treatment becomes simpler and cheaper for all parties, says Tomas Jernberg.

"Typically, new research results in the addition of a medication to a patient's regimen. However, this study shows that patients will benefit from taking one fewer drug."

But he immediately warns patients not to stop their treatment on their own accord. The current study is only about the effect of starting treatment after a small heart attack, not after a larger one. 

Always consult a doctor

Nor does it show anything about the effects of stopping treatment. More importantly, stopping medication should always be done in consultation with the treating physician.

"This is for several reasons. There may be other causes, other diagnoses, behind the use of beta-blockers. Then there is the fact that if you are going to stop, you should stop beta-blockers gradually. If you do it too quickly, you can get some heart palpitations and other discomfort. So, it is very important that you talk to your doctor before stopping any heart medication," says Tomas Jernberg.

Reference: Yndigegn T, Lindahl B, Mars K, et al. Beta-Blockers after myocardial infarction and preserved ejection fraction. N Engl J Med. 2024:NEJMoa2401479. doi: 10.1056/NEJMoa2401479

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.